Hormone Free Articles & Analysis
9 news found
If participating by phone, please dial in approximately 15 minutes prior to the start of the call using (866) 503-5561 (U.S. toll-free) or (253) 336-2965, and referring to conference ID 9976995. A telephone replay will be available for 24 hours after the call at (855) 859-2056 (U.S.) or (404) 537-3406 (International), conference ID 9976995. About Evofem Biosciences Evofem ...
(NASDAQ: EVFM) today announced strong preliminary results for the fourth quarter of 2021, including record growth in net product sales of its hormone-free prescription contraceptive gel, Phexxi® (lactic acid, citric acid and potassium bitartrate). ...
"We believe this is a huge step forward toward ensuring contraceptive access for all women at zero copay under the Affordable Care Act (ACA), further reducing unintended pregnancies in the U.S., and helping women get access to Phexxi, an innovative hormone-free birth control," said Saundra Pelletier, CEO of Evofem Biosciences. ...
Chief Executive Officer Saundra Pelletier will provide an update on the commercialization of Evofem's hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate) as well as the Company's pipeline, including the ongoing Phase 3 clinical trial evaluating EVO100 for the prevention of chlamydia and gonorrhea in women and the recently ...
OB-002 was 100% effective in blocking transmission of HIV infection in a non-human primate model.1 A 15-subject Phase 1 study of vaginally administered OB-002 gel demonstrated that the OB-002 gel was safe and well tolerated, with no evidence of systemic absorption.2 Phexxi is a hormone-free, on-demand prescription contraceptive vaginal gel that was launched in ...
"We are also diligently reducing our quarterly net cash burn rate and expect it will decrease by at least $10 million from Q3 levels starting in the fourth quarter of 2021." Phexxi is a hormone-free, on-demand prescription contraceptive vaginal gel. Evofem launched its celebrity "House Rules" DTC campaign, featuring actress Annie Murphy, in September 2021 to ...
The Company's proxy statement and any other materials filed by the Company with the SEC remain unchanged and can be obtained free of charge through Evofem's website at https://evofem.investorroom.com/SEC-filings and at https://www.sec.gov/. About Evofem Biosciences Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products and product ...
This was quickly followed by a move to Endocrinology for 9 years as a senior research officer where numerous immunoassays were developed to determine the physiological functions of a number of hormones and neurotransmitters. This led to numerous (>100) publications in peer-reviewed journals and books. ...
Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that "Get Phexxi," its national direct-to-consumer (DTC) campaign aimed at broadening awareness of its non-hormonal, on-demand birth control method, Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel, achieved significant initial results. ...